Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-cesarean Pain Control Via Continuous Infusion of Ropivacaine and Diclofenac Into the Wound Versus Intrathecal Morphine
NCT01211431Phase 4Withdrawn
- Sponsor
- CHU Nîmes
- Start
- Sep 2010
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of ropivacaine, diclofenac in Post-cesarean pain, sponsored by CHU Nîmes. Planned start Sep 2010; status: withdrawn.
02
Drugs
ropivacainediclofenac
03
Conditions
Post-cesarean pain
Beyond the preview
Go deeper on NCT01211431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211431.